Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology, admits that he was once “oblivious” to his patients’ concerns about the cost of cancer treatment. However, it is important for clinicians to empathize with these fears and understand how they can factor into a patient’s care choices.
Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology, admits that he was once “oblivious” to his patients’ concerns about the cost of cancer treatment. However, it is important for clinicians to empathize with these fears and understand how they can factor into a patient’s care choices.
Transcript (slightly modified)
How does cost sharing influence outcomes in oncology?
This is a fascinating question, because I’ll tell you that for years, actually decades, patients have asked me, “What does this cost?” And I’ve been completely oblivious to that answer. And over the last 5 years I’ve realized that me being oblivious to the cost of care was inadequate because for some patients, this idea that either through tiered co-payments or even through co-insurance, that part of the cost of that care, which could in fact be quite substantial, was theirs, was going to be borne by them.
So when we look at a lot of healthcare coverage these days, that deductible factors very deeply into a patient’s care choices, into how they view different options offered to them. And this idea that patients can live with the fear of financial devastation and bankruptcy as part of their healthcare experience is something that has to give us a certain sense of humility, has to give us a certain sense of pause, and also I think forces us as practitioners to assume greater ownership over these sorts of ideas, which is something that frankly I hadn’t done previously.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More